News from scpharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 02, 2017, 08:35 ET scPharmaceuticals Announces FDA Acceptance of NDA for Furoscix (subcutaneous furosemide)

scPharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way...

Apr 26, 2017, 10:45 ET John Tucker appointed as Chief Executive Officer of scPharmaceuticals

scPharmaceuticals, Inc. a privately held biopharmaceutical company transforming patient care and healthcare costs through innovative subcutaneous...

Jan 24, 2017, 07:35 ET scPharmaceuticals Announces Start of SUBQ-HF NHLBI Study with Its Subcutaneous Furosemide Product

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery,...

Jan 04, 2017, 08:30 ET scPharmaceuticals Announces Closing of $45.6 Million in Series B Financing

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery...

Dec 20, 2016, 08:00 ET scPharmaceuticals Initiates Commercial Scale Manufacturing Program for its sc2Wear™ Furosemide Infusor

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery...

Oct 31, 2016, 02:30 ET scPharmaceuticals Announces Presentation on Subcutaneous Ceftriaxone at IDWeek 2016

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery,...

Sep 20, 2016, 10:00 ET scPharmaceuticals Announces Presentations on Subcutaneous Furosemide at HFSA Annual Meeting

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery,...

Jul 12, 2016, 08:30 ET Supernus Pharmaceuticals Founder and CEO Jack Khattar joins scPharmaceuticals Board of Directors

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery,...

Mar 28, 2016, 10:00 ET scPharmaceuticals Announces Expansion of Executive Team

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery,...

Mar 02, 2016, 10:00 ET scPharmaceuticals Announces Positive Results from Pivotal Trial of Second Program - Subcutaneous Ceftriaxone for Treatment of Bacterial Infections

scPharmaceuticals, Inc., announced today that the pivotal trial for its ceftriaxone program met the targeted end-points. The primary end-point for...

Nov 23, 2015, 04:30 ET Swiss Technology Award for scPharmaceuticals' Strategic Partner Sensile Medical

scPharmaceuticals, Inc. today announced that its strategic partner, Sensile Medical, was awarded the prestigious Swiss Technology Award in the...

Nov 10, 2015, 08:37 ET scPharmaceuticals Announces Start of Pivotal Trial for Subcutaneous Delivery of Leading Antibiotic

scPharmaceuticals, Inc., announced today that it has commenced its pivotal trial of subcutaneous administration of the antibiotic ceftriaxone for use ...

Nov 04, 2015, 08:30 ET scPharmaceuticals Announces Positive Results from Pivotal Trial of its Novel Subcutaneous Furosemide Formulation in Patients with Heart Failure

scPharmaceuticals, Inc. today announced positive results from its pharmacokinetic and pharmacodynamics phase 3 pivotal registration trial. The trial...

Apr 21, 2015, 08:30 ET scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery,...

Apr 14, 2015, 08:30 ET scPharmaceuticals Elects Dorothy Coleman to Board of Directors and Appoints Brian Piekos as Chief Financial Officer

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery,...

Feb 06, 2015, 08:30 ET scPharmaceuticals to Present at the Leerink Global Healthcare Conference

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery,...

Dec 02, 2014, 08:30 ET Leonard Schaeffer joins scPharmaceuticals Board of Directors

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery,...

Mar 26, 2014, 12:30 ET scPharmaceuticals Completes $16.0 Million Series A Financing for Development of Two Product Candidates

scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery,...